These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 27296978)

  • 21. Adherence, drug use, and treatment failure in a methadone-clinic-based program of directly administered antiretroviral therapy.
    Lucas GM; Mullen BA; McCaul ME; Weidle PJ; Hader S; Moore RD
    AIDS Patient Care STDS; 2007 Aug; 21(8):564-74. PubMed ID: 17711381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prevalence of HIV and HCV infections in patients receiving methadone maintenance treatment in Kaiyuan, Yunnan].
    Pu L; Su Y; Wang G; Bai J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Aug; 36(8):829-31. PubMed ID: 26714537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interest in use of mHealth technology in HIV prevention and associated factors among high-risk drug users enrolled in methadone maintenance program.
    Shrestha R; Karki P; Copenhaver M
    AIDS Care; 2017 Sep; 29(9):1144-1148. PubMed ID: 28478706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type and pattern of illicit drug use and access to health care services for HIV-infected people.
    Sohler NL; Wong MD; Cunningham WE; Cabral H; Drainoni ML; Cunningham CO
    AIDS Patient Care STDS; 2007; 21 Suppl 1():S68-76. PubMed ID: 17563292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV infection as a predictor of methadone maintenance outcomes in Chinese injection drug users.
    Zhao L; Holzemer WL; Johnson M; Tulsky JP; Rose CD
    AIDS Care; 2012; 24(2):195-203. PubMed ID: 21780984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City.
    Hartel DM; Schoenbaum EE
    Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):107-15. PubMed ID: 9722816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study on the incidence and risk factors of HCV infection among heroin addicts who were on methadone maintenance treatment in Dehong prefecture,Yunnan province].
    Duan S; Han J; Tang RH; Yang YC; Xiang LF; Ye RH; Yang SS; Yang YB; Long YC; Li GQ; Yin MS; Pang L; Rou KM; Wu ZY; He N
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Jun; 34(6):552-6. PubMed ID: 24125601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medication assisted treatment in the treatment of drug abuse and dependence in HIV/AIDS infected drug users.
    Kresina TF; Bruce RD; McCance-Katz EF
    Curr HIV Res; 2009 Jul; 7(4):354-64. PubMed ID: 19601770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of health services for people who use drugs in Central Asia: findings of a quantitative survey in Kazakhstan and Kyrgyzstan.
    Rosenkranz M; Kerimi N; Takenova M; Impinen A; Mamyrov M; Degkwitz P; Zurhold H; Martens MS
    Harm Reduct J; 2016 Jan; 13():3. PubMed ID: 26817827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A longitudinal and case-control study of dropout among drug users in methadone maintenance treatment in Haiphong, Vietnam.
    Khue PM; Tham NT; Thanh Mai DT; Thuc PV; Thuc VM; Han PV; Lindan C
    Harm Reduct J; 2017 Aug; 14(1):59. PubMed ID: 28854943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coverage of harm reduction services and HIV infection: a multilevel analysis of five Chinese cities.
    Wu Q; Kamphuis C; Duo L; Luo J; Chen Y; Richardus JH
    Harm Reduct J; 2017 Feb; 14(1):10. PubMed ID: 28193236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Linkage into care among newly diagnosed HIV-positive individuals tested through outreach and facility-based HIV testing models in Mbeya, Tanzania: a prospective mixed-method cohort study.
    Sanga ES; Lerebo W; Mushi AK; Clowes P; Olomi W; Maboko L; Zarowsky C
    BMJ Open; 2017 Apr; 7(4):e013733. PubMed ID: 28404611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mortality in an urban cohort of HIV-infected and at-risk drug users in the era of highly active antiretroviral therapy.
    Kohli R; Lo Y; Howard AA; Buono D; Floris-Moore M; Klein RS; Schoenbaum EE
    Clin Infect Dis; 2005 Sep; 41(6):864-72. PubMed ID: 16107987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A qualitative study of barriers to and facilitators of optimal engagement in care among PLWH and substance use/misuse.
    Kuchinad KE; Hutton HE; Monroe AK; Anderson G; Moore RD; Chander G
    BMC Res Notes; 2016 Apr; 9():229. PubMed ID: 27103162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First Report of Gender Based Violence as a Deterrent to Methadone Access Among Females Who Use Heroin in Dar es Salaam, Tanzania.
    Balaji D; Mlunde LB; Tran OC; Lambdin B; Mbwambo J; Nyandindi C; Matiko E; Copenhaver M; Douglas Bruce R
    AIDS Behav; 2017 Jul; 21(7):2093-2100. PubMed ID: 27752867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medication persistence of HIV-infected drug users on directly administered antiretroviral therapy.
    Ing EC; Bae JW; Maru DS; Altice FL
    AIDS Behav; 2013 Jan; 17(1):113-21. PubMed ID: 22105340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy.
    Bouhnik AD; Préau M; Vincent E; Carrieri MP; Gallais H; Lepeu G; Gastaut JA; Moatti JP; Spire B;
    Antivir Ther; 2005; 10(1):53-61. PubMed ID: 15751763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between menopause symptoms and HIV risk among midlife women in methadone treatment: a pilot study.
    Tuchman E; Pennington LE; Kull RM; Daneshyar S
    Subst Use Misuse; 2013 Jun; 48(9):711-8. PubMed ID: 23607674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perceived access and barriers to care among illicit drug users and hazardous drinkers: findings from the Seek, Test, Treat, and Retain data harmonization initiative (STTR).
    Matsuzaki M; Vu QM; Gwadz M; Delaney JAC; Kuo I; Trejo MEP; Cunningham WE; Cunningham CO; Christopoulos K
    BMC Public Health; 2018 Mar; 18(1):366. PubMed ID: 29554894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.